In the case of hepatocellular carcinoma, these aggressive properties are associated with enhanced Notch signaling, which is activated by the iNOS-NO-sGC-PKG pathway in tumor-specific CSL cells with positive expression of CD24 and CD133 [168]. The gene discussed is NOS2; the disease is neoplasm.